Table 4.

Preoperative adverse effects in the two treatment groups and findings during treatment

	Premenopausal women		Postmenopausal women
	Self-administered vaginal placebo (n = 31)	Self-administered vaginal misoprostol (n = 34)	Self-administered vaginal placebo (n = 10)	Self-administered vaginal misoprostol (n = 11)
Mean level of reported preoperative pain* (SD)	0.45 (1.2)	2.2 (2.5)	0.2 (0.6)	1.1 (2.8)
Occurrence of bleeding, n (%)	1 (3)	7 (21)	0	1 (8)
Shivering, n (%)	0	1 (3)	1 (10)	0
Diarrhoea, n (%)	0	1 (3)	0	0
Nausea, n (%)	1 (3)	0	0	1 (9)
Vaginal discharge, n (%)	1 (3)	0	0	0

^*Measured with a visual analogue scale score, ranging from 0 (no pain) to 10 (unbearable pain).